The Obesity Week meeting was held in San Antonio, Texas, over November 3 to 6, 2024. Highlights from the conference included the latest data from drug candidates offering new therapeutic interventions related to the management of obesity and improving body composition. Preclinical and clinical research covering investigational assets with novel mechanisms of action was also presented.

This post-meeting report features commentary from our analysts on specific presentations. It also includes a compilation of data events added in conjunction with the meeting.